HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.

AbstractAIMS:
A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).
MATERIALS AND METHODS:
In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin.
KEY FINDINGS:
The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.
SIGNIFICANCE:
The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection.
AuthorsAbdo A Elfiky
JournalLife sciences (Life Sci) Vol. 248 Pg. 117477 (May 01 2020) ISSN: 1879-0631 [Electronic] Netherlands
PMID32119961 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Antiviral Agents
  • IDX184
  • Viral Proteins
  • remdesivir
  • Adenosine Monophosphate
  • Ribavirin
  • Guanosine Monophosphate
  • Guanosine Triphosphate
  • RNA-Dependent RNA Polymerase
  • Alanine
  • Uridine Triphosphate
  • Sofosbuvir
Topics
  • Adenosine Monophosphate (analogs & derivatives, chemistry, metabolism)
  • Alanine (analogs & derivatives, chemistry, metabolism)
  • Alphacoronavirus (enzymology, genetics)
  • Amino Acid Sequence
  • Antiviral Agents (chemistry, metabolism)
  • Betacoronavirus (enzymology, genetics)
  • COVID-19
  • Catalytic Domain
  • Computational Biology (methods)
  • Coronavirus Infections (drug therapy, virology)
  • Drug Repositioning (methods)
  • Guanosine Monophosphate (analogs & derivatives, chemistry, metabolism)
  • Guanosine Triphosphate (chemistry, metabolism)
  • Humans
  • Molecular Docking Simulation
  • Pneumonia, Viral (drug therapy, virology)
  • Protein Binding
  • Protein Conformation, alpha-Helical
  • Protein Conformation, beta-Strand
  • Protein Interaction Domains and Motifs
  • RNA-Dependent RNA Polymerase (antagonists & inhibitors, chemistry, metabolism)
  • Ribavirin (chemistry, metabolism)
  • SARS-CoV-2
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Sofosbuvir (chemistry, metabolism)
  • Thermodynamics
  • Uridine Triphosphate (chemistry, metabolism)
  • Viral Proteins (antagonists & inhibitors, chemistry, metabolism)
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: